... is anticipated the drug manufacturers will (in our view eventually) help curbreliance on imports and lower prices of retail medicines in the country as a result of increased localcompetition, according to Dr Aisha al-Ansari of ...  |  more...

... an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. The report identifies the key trends in the healthcare market of Jordan. The report also provides insights on the demographic, regulatory, reimbursement landscape and ...  |  more...

... healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into ...  |  more...

... more effective marketing from players in this area. Consumers increasingly regard herbal/traditional products as safe and gentle and also have growing confidence in these products’ efficacy. Euromonitor International's Herbal/Traditional Products in Saudi Arabia report offers ...  |  more...

... the Saudi Arabian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and provides insights on the demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report ...  |  more...

... network. Nevertheless, we expect the preferencefor generic medicines to increase in line with the formation of programmes such as the Pharmacy BenefitManagement (PBM) scheme, which will seek to increase the uptake of lower-priced drugs according ...  |  more...

... generic drugmakers pursuing the local market, focus willshift from patented drugs to generic over the long term. While this will boost overall local production,the market will remain heavily reliant on imports. Despite a top-class healthcare ...  |  more...

... government'sfiscal austerity and sick funds traditionally keep the most expensive innovative drugs and treatmentsunavailable. Additionally, as healthcare providers are prohibited from taking on debt, the shortagemeans that cheaper generics and low staff salaries have to ...  |  more...

... Central America Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems” provides key market data on the Middle East and Africa and South and Central America Healthcare IT market ...  |  more...

... size and political instability that may stall the reform of itshealthcare system. Nevertheless, healthcare expenditure growth will continue to be driven by theexpansion of facilities as well as by the country's disease profile, with Kuwaitis, ...  |  more...

... of capital into private healthcare,which investors currently view as a ‘cannot lose’ safe haven because of the region’s epidemiologicalprofile and incentives for investment, could lead to an overcapacity bubble. This, in turn, will increasecompetition and ...  |  more...

... enter through tie-ups and acquisitions of innovative local start-up companies. Headline Expenditure Projections Pharmaceuticals: ILS7.08bn (US$1.98bn) in 2011 to ILS7.42bn (US$1.93bn) in 2012; +4.8% in local currency terms and -2.5% in US dollar terms. Local ...  |  more...

... is very positive for the healthcare industry. Furthermore, the announcement and allocation of various tenders and contracts for health facility construction and fitting helps to dispel our fear that real public healthcare expenditure would not ...  |  more...